Octadecylamine

Octadecylamine

SCHEMBL4067737

CCCCCCCCCCCCCCCCCCN.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
ALOX15 P16050 1/20 0.52
TSHR P16473 4/20 0.50
LMNA P02545 2/20 0.50
PTPN11 Q06124 1/20 0.49
PLK1 P53350 1/20 0.49
CA12 O43570 1/20 0.49
CA9 Q16790 1/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP3A4 P08684 2/20 0.49
RECQL P46063 1/20 0.49
NR1I2 O75469 1/20 0.49
CHRM2 P08172 1/20 0.49
ADRA2A P08913 1/20 0.49
MAPT P10636 1/20 0.49
OPRK1 P41145 1/20 0.49
HTR2B P41595 1/20 0.49
SLC6A3 Q01959 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL11415642 1.00 ALDH1A1 (0.55) ALDH1A1ALOX15TSHRLMNAPTPN11
Octadecylamine SCHEMBL30381430 1.00 ALDH1A1 (0.55) ALDH1A1ALOX15TSHRLMNAPTPN11
Octadecylamine SCHEMBL30381571 1.00 ALDH1A1 (0.55) ALDH1A1ALOX15TSHRLMNAPTPN11
Dodecylamine SCHEMBL5968460 1.00 ALDH1A1 (0.55) ALDH1A1ALOX15TSHRLMNAPTPN11
Phthalic Acid SCHEMBL28116915 0.98 ALDH1A1 (0.54) ALDH1A1ALOX15TSHRLMNAPTPN11
SCHEMBL30150449 0.91 MEN1 (0.49) ALDH1A1ALOX15TSHRLMNAPTPN11
Phthalic Acid SCHEMBL29793929 0.90 ALDH1A1 (0.64) ALDH1A1ALOX15TSHRLMNAPTPN11
Phthalic Acid SCHEMBL28653607 0.90 ALDH1A1 (0.64) ALDH1A1ALOX15TSHRLMNAPTPN11
Phthalic Acid SCHEMBL167309 0.90 ALDH1A1 (0.64) ALDH1A1ALOX15TSHRLMNAPTPN11
Phthalic Acid SCHEMBL28300242 0.90 ALDH1A1 (0.64) ALDH1A1ALOX15TSHRLMNAPTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108795306-A A kind of water proof anti-seepage high temperature resistant telecommunications electric insulating tape 安徽省通信产业服务有限公司 2018-11-13 CN disclosed
CN-107523433-A A kind of seaming roll cleaning agent 马鞍山市康辉纸箱纸品有限公司 2017-12-29 CN disclosed
US-9314021-B2 Formulations containing insect repellent compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2016-04-19 US disclosed
US-20140288167-A1 Formulations Containing Insect Repellent Compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 2014-09-25 US disclosed
US-8771718-B2 Formulated tick and insect repellent compositions E I DU PONT DE NEMOURS AND COMPANY (US) 2014-07-08 US disclosed
US-8748477-B2 Formulations containing insect repellent compounds E I DU PONT DE NEMOURS AND COMPANY (US) 2014-06-10 US disclosed
EP-2040555-A2 FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-04-01 EP disclosed
WO-2007133683-A2 FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-11-22 WO disclosed
US-20070264297-A1 Formulated tick and insect repellent compositions 1,4Group, Inc. 2007-11-15 US disclosed
EP-1806969-A1 INSECT REPELLENT COMPOSITIONS COMPRISING DIHYDRONEPETALACTONE, AN ALCOHOL, AND AN ESTER E.I.Du pont de nemours and company (US) 2007-07-18 EP disclosed
US-20060223878-A1 Formulations containing insect repellent compounds 1,4Group, Inc. 2006-10-05 US disclosed
WO-2006050519-A1 INSECT REPELLENT COMPOSITIONS COMPRISING DIHYDRONEPETALACTONE, AN ALCOHOL, AND AN ESTER E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288167-A1 Formulations Containing Insect Repellent Compounds CAT, HNMT, MME ALDH1A1 1079/4885ALOX15 1476/4885TSHR 4703/4885
US-20060223878-A1 Formulations containing insect repellent compounds CAT, HNMT, MME ALDH1A1 1079/4885ALOX15 1476/4885TSHR 4703/4885
US-20070264297-A1 Formulated tick and insect repellent compositions MME, FNTA, ACHE ALDH1A1 3113/4885ALOX15 3460/4885TSHR 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.